Acasti Pharma Inc. (ACST)
USD 3.37
(4.01%)
USD 3.37
(4.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.33 Million | -15.91 Million | -17.23 Million | -14.31 Million | -22.94 Million | -24.32 Million |
| Net Income | -12.85 Million | -42.42 Million | -9.81 Million | -19.67 Million | -25.51 Million | -38.62 Million |
| Depreciation & Amortization | 11 Thousand | 124 Thousand | - | 924 Thousand | 2.32 Million | 2.11 Million |
| Deferred income taxes | -1.83 Million | -9.54 Million | -648 Thousand | 8.94 Million | 1.36 Million | 435.14 Thousand |
| Stock-based compensation | 913 Thousand | 1.81 Million | 1.33 Million | 1.17 Million | 1.95 Million | 779.65 Thousand |
| Change in working capital | -1.28 Million | 181 Thousand | -2.78 Million | -5.94 Million | -3.21 Million | 6.05 Million |
| Other non-cash items | 1.73 Million | 33.94 Million | -5.31 Million | 264 Thousand | 145 Thousand | 4.9 Million |
| Investing Cash Flow | 104 Thousand | 13.15 Million | -3.52 Million | -9.85 Million | 8.13 Million | -9.08 Million |
| Investments in PPE | -22 Thousand | -17 Thousand | - | -69 Thousand | -319 Thousand | -524.26 Thousand |
| Acquisitions | 111 Thousand | 5.03 Million | - | 9.87 Million | 2.24 Million | 1.23 |
| Investment purchases | -6.55 Million | -5.01 Million | -34.92 Million | -9.81 Million | -1.92 Million | -17.78 Million |
| Sales/Maturities of investments | 6.56 Million | 18.18 Million | 31.4 Million | 21 Thousand | 10.38 Million | 8.93 Million |
| Other Investing Activities | 89 Thousand | -5.03 Million | -4403.24 | -9.87 Million | -2.24 Million | 287.59 Thousand |
| Financing Cash Flow | 7.35 Million | 304 Thousand | - | 59.49 Million | 13.17 Million | 44.08 Million |
| Debt repayment | - | - | - | - | -1.55 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.35 Million | 304 Thousand | - | 59.33 Million | 6.98 Million | 43.35 Million |
| Other Financing Activities | 7.35 Million | 410.86 Thousand | - | 158 Thousand | 7.75 Million | 726.48 Thousand |
| Accounts receivables | 80 Thousand | -408.16 | -18 Thousand | 58 Thousand | 581 Thousand | -620 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.36 Million | 181.4 Thousand | -2.76 Million | -6 Million | -3.79 Million | 6.67 Million |
| Cash at beginning of period | 27.87 Million | 30.33 Million | 50.94 Million | 14.24 Million | 16.87 Million | 6.15 Million |
| Cash at end of period | 23 Million | 27.87 Million | 30.33 Million | 50.94 Million | 14.24 Million | 16.86 Million |
| Capital Expenditure | -22 Thousand | -17 Thousand | - | -69 Thousand | -319 Thousand | -524.26 Thousand |
| Effect of forex changes on cash | - | -8000.00 | 153 Thousand | 1.38 Million | -1 Million | 35.94 Thousand |
| Net cash flow / Change in cash | -4.87 Million | -2.46 Million | -20.6 Million | 36.7 Million | -2.63 Million | 10.7 Million |
| Free Cash Flow | -12.35 Million | -15.93 Million | -17.23 Million | -14.38 Million | -23.26 Million | -24.84 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.61 Million | -12.85 Million | -3.16 Million | -2.39 Million | -3.27 Million | -4.02 Million |
| Depreciation & Amortization | 1000.00 | 11 Thousand | 1000.00 | 1000.00 | 2000.00 | 7000.00 |
| Deferred income taxes | -724 Thousand | -1.83 Million | -889 Thousand | -208 Thousand | -446 Thousand | -289 Thousand |
| Stock-based compensation | 238 Thousand | 913 Thousand | 229 Thousand | 326 Thousand | 280 Thousand | 78 Thousand |
| Change in working capital | 900 Thousand | -1.28 Million | 687.6 Thousand | 506 Thousand | -464 Thousand | -2.02 Million |
| Other non-cash items | -2.2 Million | 1.73 Million | 70.55 Thousand | -126 Thousand | 1.78 Million | 13 Thousand |
| Investing Cash Flow | -15 Thousand | 104 Thousand | 6.49 Million | -6.55 Million | 110 Thousand | - |
| Investments in PPE | - | -22 Thousand | -22 Thousand | - | - | - |
| Acquisitions | - | 111 Thousand | 1912.31 | -976.58 | 110.07 Thousand | - |
| Investment purchases | -15 Thousand | -6.55 Million | -54.35 Thousand | -6.55 Million | - | - |
| Sales/Maturities of investments | - | 6.56 Million | 6.56 Million | - | - | - |
| Other Investing Activities | - | 89 Thousand | 88.09 Thousand | 976.58 | -73.00 | - |
| Financing Cash Flow | - | 7.35 Million | 61.02 Thousand | -65.33 Thousand | 7.35 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.35 Million | 61.02 Thousand | -65.33 Thousand | 7.33 Million | - |
| Other Financing Activities | - | 7.35 Million | 7.33 Million | - | 21 Thousand | - |
| Accounts receivables | 326 Thousand | 80 Thousand | 235.71 Thousand | -190.73 Thousand | 23.25 | 35 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 574 Thousand | -1.36 Million | 451.88 Thousand | 696.73 Thousand | -464.02 Thousand | -2.06 Million |
| Cash at beginning of period | 23 Million | 27.87 Million | 18.54 Million | 26.99 Million | 21.63 Million | 27.87 Million |
| Cash at end of period | 19.39 Million | 23 Million | 23 Million | 18.54 Million | 26.99 Million | 21.63 Million |
| Capital Expenditure | - | -22 Thousand | -22 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | -65.33 Thousand | 65.33 Thousand | 2000.00 | -2000.00 |
| Net cash flow / Change in cash | -3.61 Million | -4.87 Million | 4.46 Million | -8.44 Million | 5.35 Million | -6.24 Million |
| Free Cash Flow | -3.59 Million | -12.35 Million | -2.19 Million | -1.89 Million | -2.11 Million | -6.24 Million |
BYDGF
KEY-PI
9956
1020
2603
TRST